Project Grant R35GM162319
- Federal Project Grant Award Summary The University of Pennsylvania received a $446,875 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 8, 2025, with a completion date of June 30, 2030. This award supports fundamental biomedical research aimed at deciphering novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress. The research...
- Federal Project Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 15, 2026, with completion expected January 31, 2031. This five-year research project focuses on elucidating the molecular mechanisms of cell migration by investigating post-translational modifications of tubulin, specifically...
- Federal Grant Award Summary The University of South Florida received a $412,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025 through April 30, 2030. This research initiative aims to elucidate the molecular mechanisms of cell death pathways, specifically apoptosis and necroptosis, with applications for treating diseases characterized by dysregulated cell death including...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $388,750 Project Grant to The Washington University on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The research initiative, funded through January 31, 2030, investigates phosphatidylserine (PS) neighborhood proteins on apoptotic cells and their role in efferocytosis—the process by which phagocytes recognize and engulf dying cells. The project...
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $453,750 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the metabolic control of membrane lysis and regulated cell death. The award, obligated on August 8, 2025, with completion expected June 30, 2030, supports fundamental research exploring how metabolic pathways regulate the...
- Federal Project Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 13, 2026, with completion scheduled for January 31, 2031. This Maximizing Investigators' Research Award (MIRA) funds fundamental research investigating the mechanisms by which cells regulate messenger ribonucleic acid (mRNA)...
- Federal Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. This award supports the development of computational methods and tools designed to enhance the application of Nuclear Magnetic Resonance (NMR) spectroscopy in biomedical research. The project leverages...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences awarded a Project Grant of $397,771 (awarded August 1, 2025, with completion by May 31, 2030) under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research investigating the mechanisms and consequences of lipid accumulations in necroptosis. The research, conducted at The Research Foundation for the State University of New York (performing the sponsored research on...
- Federal Grant Award Summary Award Details: The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $249,000 to the University of California, San Diego for a three-year project period from September 1, 2025, through August 31, 2028. This Project Grant funds investigator-initiated basic biomedical research that advances understanding of biological processes and supports disease diagnosis, treatment, and prevention...
- Federal Grant Award Summary The University of Connecticut received a $607,470 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through February 28, 2030. The project, titled "Enabling Mass Spectrometry-Based Mid-Down Sequencing of Large Modified RNAs," aims to develop advanced analytical methodologies to address critical limitations in characterizing...
The University of Connecticut Health Center received a $423,352 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 18, 2026, through February 28, 2031. This award supports fundamental biomedical research investigating dead cell-phagocyte interactions at the phagosomal interface to advance understanding of cellular death processes and immune responses. The research employs an innovative proximity-labeling technique called PhagoPL to profile protein compositions within phagosomes—the vesicles formed when immune cells internalize dead cells—enabling researchers to decode how cells recognize and process different types of cell death signals including apoptosis, necroptosis, and pyroptosis. The project directly contributes to NIGMS's mission of supporting basic research that enhances understanding of biological processes and establishes foundations for advances in disease diagnosis, treatment, and prevention. By systematically exploring the molecular mechanisms governing efferocytosis (the cellular clearance of dead cells) and the subsequent immune signaling pathways, this research holds potential applications for developing more effective therapeutic strategies against diseases including cancer and for preventing harmful immune complications such as autoimmune and fibrotic diseases. The five-year project period supports investigation of how phagosomal composition adapts to different cellular cargo and death modalities, directly expanding fundamental knowledge of cell recognition mechanisms.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $423.4k | 3/18/26 |